References
- Holmstrom S, Buchholz P, Walt J, et al. The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries. Curr Med Res Opin 2006;22:897–905
- Holmstrom S, Buchholz P, Walt J, et al. Analytic review of bimatoprost, lastanoprost and travoprost in primary open angle glaucoma. Curr Med Res Opin 2005;21:1875–83
- Van der Valk R, Webers CAB, Schorten JSAG, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs. A meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177–85
- Konstas AG, Katsimbris JM, Lallos N, et al. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients. Ophthalmology 2005;112: 262–6
- Orzalesi N, Rossetti L, Bottoli A, et al. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 2006;113:239–46